• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Kidney Function Differs by Diabetes Onset Timing Across Solid Organ Transplants

by
November 21, 2026
in Health
Reading Time: 4 mins read
0
Kidney Function Differs by Diabetes Onset Timing Across Solid Organ Transplants

Kidney Function Differs by Diabetes Onset Timing Across Solid Organ Transplants

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A single-center retrospective study evaluating 113 solid-organ transplant recipients with diabetes found substantial rates of kidney impairment and above-target glycemia, alongside notable baseline differences between individuals with pretransplant diabetes mellitus and post-transplant diabetes mellitus. Assessed at an outpatient index visit between May 2017 and May 2026, the overall patient cohort exhibited a mean estimated glomerular filtration rate of 60.77 ± 28.39 mL/min/1.73 m² and a mean glycated hemoglobin of 7.40 ± 1.84%. Nearly half of the participants presented with diminished renal function, with 49.5% recording an estimated glomerular filtration rate below 60 mL/min/1.73 m², while 53.2% displayed glycated hemoglobin levels exceeding 7% at their single cross-sectional assessment.

Diabetes is recognized as a major contributor to morbidity following solid-organ transplantation, yet clinical comparisons examining renal function and glycemic control between pretransplant diabetes mellitus and post-transplant diabetes mellitus have remained limited in medical literature. This gap in evidence is especially pronounced for cohorts in which most recipients have received an organ other than a kidney. To evaluate these dynamics, researchers analyzed cross-sectional outpatient records to describe kidney function, albuminuria, glycemic control, and medical treatment patterns, establishing the primary comparison between pretransplant and post-transplant diabetes alongside secondary exploratory assessments.

The investigated cohort consisted predominantly of non-kidney organ recipients, comprising 51.3% liver transplant recipients, 36.3% kidney transplant recipients, and 12.4% heart transplant recipients. Within this group, post-transplant diabetes mellitus was diagnosed in 61.6% of patients. Across the entire sample, the median time elapsed since transplantation was 9 years, with an interquartile range spanning from 5 to 16 years. Albuminuria, defined by a urinary albumin-to-creatinine ratio of 30 mg/g or greater, was identified in 45.9% of the 98 patients who had an available urinary measurement, demarcating a high-risk subgroup under Kidney Disease: Improving Global Outcomes criteria.

Marked differences emerged when comparing patients based on the timing of diabetes onset. Recipients with pretransplant diabetes had survived a significantly shorter median time since their transplant procedure compared to those with post-transplant diabetes, recording 6.0 years versus 11.0 years. Patients with pretransplant diabetes were also nominally older, presenting a median age of 64.0 years compared with 60.0 years in the post-transplant group. Furthermore, recipients with pretransplant diabetes displayed a lower unadjusted mean estimated glomerular filtration rate of 53.06 ± 21.82 mL/min/1.73 m², compared to 65.78 ± 31.02 mL/min/1.73 m² in those who developed diabetes post-transplantation.

Categorical distributions of renal impairment highlighted this disparity, as patients with pretransplant diabetes were significantly more likely to fall into estimated glomerular filtration rate categories G3 through G5, encompassing 68.3% of pretransplant cases compared to 37.3% of post-transplant cases. In contrast to renal filtration measures, glycemic regulation showed remarkable parity between the cohorts, as no statistically significant difference in glycated hemoglobin was detected between pretransplant and post-transplant diabetes groups. Urinary albumin-to-creatinine ratios also demonstrated no statistically significant difference between diabetes groups once multiple testing adjustments were applied via Holm and Benjamini–Hochberg procedures.

To evaluate potential confounding factors, the investigative team specified sequential multivariable linear regression models founded upon an explicit causal framework. In Model 1 unadjusted analyses, filtration differences favored the post-transplant cohort. In Model 2, which adjusted for age, sex, transplanted organ type, and time elapsed since transplantation, the estimated glomerular filtration rate remained 12.7 mL/min/1.73 m² higher among recipients with post-transplant diabetes. However, in Model 3, which added further statistical adjustments for body mass index, glucocorticoid therapy, and calcineurin-inhibitor exposure, this difference attenuated to 7.8 mL/min/1.73 m² with a 95% confidence interval of −4.9 to 20.5 mL/min/1.73 m².

Sensitivity evaluations that excluded kidney transplant recipients altered the magnitude of these mathematical associations. In the non-kidney subcohort, the unadjusted estimated glomerular filtration rate difference between post-transplant and pretransplant diabetes widened to 19.2 mL/min/1.73 m² with a 95% confidence interval of 6.6 to 31.7 mL/min/1.73 m². When applying the covariates of Model 2 to this non-kidney group, the estimated filtration advantage for post-transplant diabetes attenuated to 10.5 mL/min/1.73 m² with a 95% confidence interval crossing zero, spanning −3.1 to 24.0 mL/min/1.73 m².

Exploratory analyses within the study identified critical therapeutic and biochemical patterns across the recipient population. In an exploratory regression model, low-density lipoprotein cholesterol was positively associated with the urinary albumin-to-creatinine ratio, demonstrating a 1.20-fold increase per 10 mg/dL. Regarding contemporary pharmacotherapy, only 40% of the transplant recipients presenting with albuminuria were receiving a sodium-glucose cotransporter 2 inhibitor. Additionally, secondary comparisons conducted between early-onset and late-onset post-transplant diabetes revealed no statistically significant differences in renal function or glycemic control, although the authors noted that confidence intervals for these subgroup estimates were wide.

The study authors concluded that solid-organ transplant recipients with diabetes frequently exhibit reduced filtration rates, albuminuria, and glycated hemoglobin levels above clinical targets when assessed years after transplantation. Because reduced filtration was often non-albuminuric, albuminuria identified a distinct high-risk subgroup that remained undertreated with sodium-glucose cotransporter 2 inhibitors. Furthermore, the lower estimated filtration in pretransplant diabetes was not explained by age, sex, organ type, or post-transplant duration, but attenuated after accounting for body mass index and immunosuppressive exposure; consequently, the observed disparities reflect two differently selected populations influenced by survivorship and prevalent-user selection rather than an intrinsic biological effect of diabetes category.

Subject of Research: Kidney function and glycemic control in solid-organ transplant recipients with pretransplant versus post-transplant diabetes

Article Title: Kidney function and glycemic control in solid-organ transplant recipients with pretransplant versus post-transplant diabetes: a cross-sectional study of a predominantly non-kidney transplant cohort

Article References: Batista Ferreira, H., Bernardes Izza, L., Gonçalves Duarte, A., Farias, E., Yamashita, Y. P., Ensser, I. R., & Lauria, M. W. (2026). Kidney function and glycemic control in solid-organ transplant recipients with pretransplant versus post-transplant diabetes: a cross-sectional study of a predominantly non-kidney transplant cohort. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02359-x

Image Credits: AI Generated

DOI: 10.1186/s13098-026-02359-x

Keywords: solid-organ transplantation, pretransplant diabetes mellitus, post-transplant diabetes mellitus, kidney function, estimated glomerular filtration rate, glycemic control, HbA1c, albuminuria, urinary albumin-to-creatinine ratio, liver transplantation, kidney transplantation, heart transplantation, SGLT2 inhibitors, calcineurin inhibitors, glucocorticoids, KDIGO risk, LDL cholesterol, cross-sectional study

News Source: Jerry Hayes. (November 21, 2026). Kidney Function Differs by Diabetes Onset Timing Across Solid Organ Transplants. Scienmag.

Tags: albuminuriacalcineurin inhibitorsCross-sectional Studyestimated glomerular filtration rateglucocorticoidsglycemic controlHbA1cheart transplantationKDIGO riskKidney Functionkidney transplantationLDL cholesterolliver transplantationpost-transplant diabetes mellituspretransplant diabetes mellitusSGLT2 inhibitorssolid organ transplantationurinary albumin-to-creatinine ratio
Share12Tweet7Share2ShareShareShare1

Related Posts

Formaldehyde Injection During Biopsy Causes Oral Mucosa Necrosis

Formaldehyde Injection During Biopsy Causes Oral Mucosa Necrosis

November 21, 2026
Blinatumomab and Autologous Stem Cell Transplant Produce Sustained Leukemia Remission in HIV

Blinatumomab and Autologous Stem Cell Transplant Produce Sustained Leukemia Remission in HIV

November 21, 2026

Pediatric Dehydration Risks Increase as Climate Change Intensifies Extreme Heatwaves

November 21, 2026

Oncology Antimicrobial Stewardship in Bahrain Linked to Reduced Antibiotic Exposure and Readmissions

November 21, 2026

POPULAR NEWS

  • Phase I Trial of Novel Antibody-Drug Conjugate Shows Early Efficacy in Sarcoma

    Phase I Trial of Novel Antibody-Drug Conjugate Shows Early Efficacy in Sarcoma

    29 shares
    Share 12 Tweet 7
  • New Unified Contraction Framework Establishes Fixed Point Results in Metric Spaces

    29 shares
    Share 12 Tweet 7
  • Early Skin Molecular Signatures Predict Atopic Dermatitis Risk in Asian Infant Cohort

    29 shares
    Share 12 Tweet 7
  • Review Finds Minor Cannabinoids Lack Established Clinical Efficacy for ADHD Treatment

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Formaldehyde Injection During Biopsy Causes Oral Mucosa Necrosis

Lung Growth Factors Fail to Protect Stem Cells from Hyperoxia

Bat Fly Found on Silver-Tipped Bat in Central Amazon

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.